Past performance
About Chandan Healthcare Ltd Chandan Healthcare Limited, established on September 3, 2003, is a prominent healthcare service provider specializing in advanced pathological and radiological diagnostics. Operating primarily in North India, it provides a diverse range of testing services, including biochemistry, hematology, microbiology, and immunology, alongside radiological services such as X-rays, CT scans, and MRIs. The company has a robust network comprising a flagship laboratory, 7 central laboratories, 26 satellite centers, and over 300 collection centers as of August 31, 2024. Several of these facilities carry NABL and NABH accreditations, emphasizing its commitment to high-quality diagnostics.
The company has steadily expanded its presence, starting with its first diagnostic center in Lucknow in 2003, followed by Dehradun in 2013. Chandan Healthcare also operates a chain of retail pharmacies and wholesale distribution outlets across Uttar Pradesh, Uttarakhand, and Delhi. In 2018, the company ventured into tertiary care by establishing Chandan Hospital Limited, a 300-bed multi-super specialty hospital in Lucknow, further strengthening its regional reputation in healthcare services.
Chandan Healthcare boasts an extensive test menu, offering 1,118 diagnostic tests across various specialties. These include routine and specialized pathology tests like molecular pathology, as well as sophisticated radiology services supported by 11 CT scanners and 4 MRI machines. Its diagnostic capabilities and dedicated services position the company as a vital healthcare partner for professionals and patients alike.
The company plans to go public via an IPO aggregating up to 68,99,936 equity shares, comprising a fresh issue of 46,00,000 equity shares and an offer for sale of 22,99,936 equity shares, signaling its ambitions for further growth and expansion in the healthcare diagnostics sector.
Performance overview